NEWPORT BEACH, Calif. — May 12, 2026 — Leonhardt Ventures LLC announced today a new provisional patent application exclusively licensed to Lionheart Health, Inc. covering systems and methods for the bioelectric activation and control of Wnt signaling pathways for regenerative medicine and longevity applications.
The patent application describes the use of frequency-specific bioelectric stimulation, microcurrents, PEMF, conductive biomaterials, implantable stimulators, wearable electroceutical systems, and AI-guided signaling control systems to activate and regulate Wnt signaling pathways associated with tissue regeneration and cellular repair.
Potential applications described in the filing include:
- Hair regeneration
- Hearing restoration
- Arthritis and cartilage repair
- Muscle regeneration
- Skin rejuvenation
- Bone density improvement
- Neural repair
- Organ regeneration
- Longevity enhancement
The invention further describes combining Wnt pathway modulation with:
- Klotho enhancement
- Stem cells
- Exosomes
- PRF
- Bioelectric enhanced peptides
- Red light therapy
- PEMF
- Acoustic pulse technologies
- Conductive hydrogels
- AI-driven adaptive stimulation systems
According to the filing, bioelectric signaling may allow more precise spatial and temporal control of regenerative pathways than conventional pharmaceutical approaches alone.
“Our goal is to create programmable regenerative medicine systems capable of activating the body’s own repair pathways using targeted bioelectric signaling,” said Howard J. Leonhardt. “Wnt signaling is one of the master regulators of regeneration throughout the body. We believe bioelectric control of Wnt pathways, especially when combined with Klotho enhancement and regenerative biologics, could become foundational technology for next-generation regenerative medicine.”
The filing includes applications involving:
- Hair follicle regeneration
- Cochlear hair cell regeneration
- Stem cell homing
- Chondrocyte activation
- Neural regeneration
- Anti-fibrotic signaling balance
- Regenerative microenvironment creation
The technologies described may potentially integrate into existing and future Lionheart Health programs including:
- HairCell™
- EarCell™
- OrthoStim™
- Brain Band™
- BodStim™
- Lionheart 240 Stimulus™
The company stated that future development efforts may include:
- Wearable regenerative electroceuticals
- Implantable regenerative stimulators
- Smart conductive regenerative patches
- Bioelectric hydrogel scaffolds
- AI-optimized regenerative signaling systems
The filing expands Leonhardt Ventures’ growing intellectual property portfolio focused on bioelectric stimulation controlled protein expression and regenerative medicine technologies.
About Leonhardt Ventures LLC
Founded in 1982, Leonhardt Ventures LLC is an innovation accelerator and regenerative medicine technology developer focused on bioelectric signaling, stem cells, longevity therapeutics, cardiovascular innovation, neurostimulation, and organ regeneration technologies.
About Lionheart Health, Inc.
Lionheart Health, Inc. is focused on commercialization of bioelectric stimulation controlled protein expression technologies for longevity, aesthetics, regenerative medicine, muscle health, brain health, sexual health, joint health, hair regeneration, and wellness applications through memberships, clinics, devices, supplements, and strategic licensing partnerships.
Forward-Looking Statements
This press release contains forward-looking statements regarding investigational technologies, potential therapeutic applications, regulatory pathways, and future development activities. These statements are based on current expectations and involve risks and uncertainties. The technologies described are investigational and may not be approved for medical use in all jurisdictions.